RichFakirNSE · BSEOpen live analysis →

Dhampur Bio Organics Ltd

DBOL · Fast Moving Consumer Goods

The company processes sugarcane to produce refined and pharmaceutical-grade sugar, ethanol for fuel blending, and country liquor, while also generating renewable power from agricultural by-products.

Our view
Avoid
Quality score
29
Discount to fair value
-37%
See the full interactive analysis — quality radar, 12-year financials & more →
Fair value / share
₹86
Discount to fair value
-37%
Quality score
29/100
Return on equity
6.3%
Revenue growth (5y)
4.0%
P/E
30.5

Competitive advantage

The company lacks a durable moat as evidenced by low average ROCE (5.5%) and net margins (3.1%), which are typical of a commodity business. While it has a cost-efficient integrated model and specialized pharma-grade sugar capacity, these do not provide sufficient pricing power to offset cyclical cane costs and government-regulated ethanol pricing.

Capital allocation

Capital has been deployed toward converting distillery capacity to dual-feed (grain and molasses) to reduce seasonal dependency and expanding country liquor bottling lines. However, the high debt-to-equity ratio (1.03) and low returns on capital suggest that these investments have yet to generate significant shareholder value.

Bear case

The investment collapsed as the company remained trapped in a commodity cycle where rising cane costs and government-capped ethanol prices squeezed margins to the breaking point. Despite heavy capital expenditure into dual-feed distilleries, the incremental returns failed to cover the cost of debt, leading to a liquidity crunch. The combination of stagnant revenue growth and a continued collapse in earnings per share eventually forced a fire sale of assets to service the high leverage, leaving equity holders with permanent capital loss.

Questions & answers

Is Dhampur Bio Organics Ltd (DBOL) a good business?

RichFakir rates Dhampur Bio Organics Ltd's business quality as poor — 29/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.

Is Dhampur Bio Organics Ltd overvalued or undervalued?

On our model, Dhampur Bio Organics Ltd is trading about 37% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.

What is RichFakir's verdict on Dhampur Bio Organics Ltd (DBOL)?

RichFakir's educational verdict on Dhampur Bio Organics Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.

What is Dhampur Bio Organics Ltd's fair value?

RichFakir's educational estimate of Dhampur Bio Organics Ltd's fair value is about ₹86 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.

View the full live analysis →

Other companies

LEMERITE526095.BO532057.BOBROOKSCEWATER532825.BOSHRIKRISH505523.BO543997.BO534422.BOUMAV2RETAIL
RichFakir is an educational research tool, not investment advice. Figures are estimates from public filings and may contain errors. Do your own research.